Latest News

EVC 2025: Multidisciplinary, multi-stakeholder efforts key to setting venous disease research...

Addressing the audience at the 28th European Vascular Course (EVC 2025; 9–11 March, Maastricht, The Netherlands), Ulka Sachdev-Ost (University of Pittsburgh, Pittsburgh, USA) set...

Features

Thrombectomy gold rush set to follow ATTRACT study, experts argue

At the recent Endo Vascular Access (EVA) meeting (14–15 June, Patras, Greece), Ziv Haskal (University of Virginia School of Medicine, Charlottesville, USA) spoke to...

MedTech Insights: “This is a pivotal year for us,” says VeinWay...

With seven compassionate-use cases under its belt and commercialization in view, VeinWay—developer of the Traversa, a tool for crossing tough venous occlusions—is at a...

Videos

Before the STEVECO trial, there were no randomized controlled trial data in the chronic disease space; in its wake, has come a more robust landscape to establish an evidence base: During the 2024 Charing Cross (CX) International Symposium (April...
Kathleen Oszvath

Kathleen Ozsvath

Kush Desai

Gloria Salazar